1. Granulocyte colony-stimulating factor (G-CSF) and interleukin (IL)-8 in sera from patients with Staphylococcus aureus septicemia 
Bo Söderquist, Dan Danielsson, Hans Holmberg, Tomas Vikerfors 
Clinical Microbiology and Infection 
Volume 1, Issue 2, Pages (December 1995)
DOI: /j tb00452.x
Copyright © 1995 European Society of Clinical Infectious Diseases Terms and Conditions

2. Figure 1
Serum G-CSF concentrations in 64 patients with Staphylococcus aureus septicemia on admission, and after 1 and 2 weeks.
Clinical Microbiology and Infection 1995 1, DOI: ( /j tb00452.x)
Copyright © 1995 European Society of Clinical Infectious Diseases Terms and Conditions

3. Figure 2
Serum IL-8 concentrations in 64 patients with Staphylococcus aureus septicemia on admission, and after l and 2 weeks.
Clinical Microbiology and Infection 1995 1, DOI: ( /j tb00452.x)
Copyright © 1995 European Society of Clinical Infectious Diseases Terms and Conditions

4. Figure 3
Mean serum levels (95% confidence intervals) of G-CSF (•) and IL-8 (▪) during the first 14 days in 64 patients with Staphylococcus aureus septicemia (n = patients analyzed at indicated time).
Clinical Microbiology and Infection 1995 1, DOI: ( /j tb00452.x)
Copyright © 1995 European Society of Clinical Infectious Diseases Terms and Conditions

5. Figure 4
Mean serum levels (95% confidence intervals) of G-CSF (•) and IL-8 (▪) according to delay (number of days between onset of disease and admission to hospital) in 64 patients with Staphylococcus aureus septicemia.
Clinical Microbiology and Infection 1995 1, DOI: ( /j tb00452.x)
Copyright © 1995 European Society of Clinical Infectious Diseases Terms and Conditions

6. Figure 5
Number of patients with or without elevated G-CSF levels on admission in complicated and uncomplicated Staphylococcus aureus septicemia.
Clinical Microbiology and Infection 1995 1, DOI: ( /j tb00452.x)
Copyright © 1995 European Society of Clinical Infectious Diseases Terms and Conditions